Hypovolemic Phlebotomy Beneficial Before Liver Resection
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 11, 2024 -- For patients undergoing liver resection, hypovolemic phlebotomy reduces perioperative red blood cell transfusions compared with usual care, according to a study published online Dec. 9 in The Lancet Gastroenterology and Hepatology.
Guillaume Martel, M.D., from the University of Ottawa in Ontario, Canada, and colleagues conducted a superiority, randomized controlled trial to examine whether hypovolemic phlebotomy before liver resection is superior to usual care for reducing red blood cell transfusions. A total of 486 patients were randomly assigned to receive hypovolemic phlebotomy (removal of 7 to 10 mL/kg of whole blood without volume replacement) or usual care (245 and 241 participants, respectively); 22 and 18 patients, respectively, were excluded from the primary analysis population as they did not undergo liver resection.
The researchers found that 8 and 16 percent of patients assigned to hypovolemic phlebotomy and usual care, respectively, had a perioperative red blood cell transfusion by 30 days (difference, −8.8 percentage points; adjusted risk ratio, 0.47). Overall, 17 and 16 percent of patients allocated to hypovolemic phlebotomy and usual care, respectively, had severe complications to 30 days; overall complications to 30 days occurred in 61 and 52 percent, respectively. No postoperative mortality was seen to 90 days.
"Use of hypovolemic phlebotomy before liver transection resulted in significantly fewer perioperative red blood cell transfusions than with usual care," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip
TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...
Wearable-Derived Biorhythms Predict Complications After Appendectomy
MONDAY, July 14, 2025 -- Wearable-derived biorhythms can predict postoperative complications in children undergoing appendectomy, according to a study published online July 9 in...
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer
FRIDAY, July 11, 2025 -- Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients diagnosed with pancreatic cancer...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.